Physician profile
Aditya Das
NPI 1710470729
$7,980.91
in general payments reported to CMS, 2019-2025
11 companies · $1,068 in 2025
The $1,068 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $239 · 2021: $254 · 2022: $143 · 2023: $4,325 · 2024: $1,621 · 2025: $1,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,750 · Food and Beverage: $1,732 · Travel and Lodging: $1,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,750.00 |
| Food and Beverage | $1,731.84 |
| Travel and Lodging | $1,531.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,195.06 | 2021-2025 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $531.97 | 2019-2020 | |
| Davol INC. | $400.74 | 2023-2024 | Arista Ah Flexitip |
| Medtronic, INC. | $289.37 | 2023-2024 | Signia |
| Tela Bio, INC. | $256.24 | 2024 | Ovitex 2s |
| Baxter Healthcare | $92.01 | 2023-2024 | Perclot, Floseal |
| Cook Medical LLC | $77.93 | 2021 | |
| Ethicon US, LLC | $53.24 | 2020-2025 | Proximate |
| W. L. Gore & Associates, INC. | $36.69 | 2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Shockwave Medical, INC | $33.54 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $14.12 | 2023 | Alto Abdominal Stent Graft System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.